RESEARCH OF QUALITATIVE FEATURES OF PHARMACEUTICAL PROVIDING TO PATIENTS WITH LIVER CIRRHOSIS WITH ESTABLISHED COMPLICATIONS OF MAIN DAGNOGOSIS
DOI:
https://doi.org/10.11603/1811-2471.2015.v24.i4.5812Abstract
SUMMARY. This article presents the results of implemented frequency analysis of medical prescriptions of patients with liver cirrhosis of different etiologies. They indicate that the drugs that have been taken by patients in the hospital conditions, primarily used to treat complications of basic diagnosis. Since it has been established that hepatocellular insufficiency of different level was observed in 94 % of patients, portal hypertension – in 87.4 %, ascites – in 37.9 %. Therefore, the most often prescribed drugs were: Verospiron (Gedeon Richter, Hungary) was prescribed to 64.2 % of patients, Tiogama Turbo (Wörwag Pharma GmbH & Co, Germany) was taken ин45.8 % of patients and Duphalac syrup (Solvay Pharmaceuticals, the Netherlands) – 41 % of patients.
KEY WORDS: liver cirrhosis, primary diagnosis complications, frequency analysis, drugs used to treat liver diseases.
References
Analiz pokaznykiv fibrozuvannya pechinky u khvorykh na subkompensovanyy tsyroz / O. YE. Samohalʹsʹka, T. B. Lazarchuk, N. M. Oliynyk [ta in.] // Visnyk naukovykh doslidzhenʹ. – 2012. – № 2. – S. 29–31.
Diahnostyka i likuvannya khronichnykh nevirusnykh za khvoryuvanʹ pechinky / V. YE. Neyko, N. H. Virstyuk, O. I. Dyelʹ tsova [ta in.] // Referat naukovo-doslidnoyi roboty. – 2010. – 7 s.
Fedyak I. O. Rezulʹtaty analizu vykorystannya hepa toprotektoriv u khvorykh na tsyroz pechinky / I. O. Fedyak, O. V. Maksymenko // Zdobutky ta perspektyvy upravlin nya farmatsevtychnoyu systemoyu: mater. nauk.-prakt. kon ferentsiyi z mizhnarodnoyu uchastyu prysvyachenoyi 50-littyu stvorennya kafedry OEF LNMU im. Danyla Halytsʹko ho. – Lʹviv : Rastr-7, 2014. – S. 162–164.
Samohalʹsʹka O. YE. Porivnyalʹnyy analiz poshy renosti ta osoblyvostey perebihu tsyrozu pechinky sered cholovikiv ta zhinok // Visnyk naukovykh doslidzhenʹ. – 2008. – № 2. – S. 19–21.
Dzyubanovsʹkyy I. YA. Retrospektyvnyy analiz re zulʹtativ statsionarnoho likuvannya khvorykh iz khronichnymy
dyfuznymy zakhvoryuvannyamy pechinky v Ternopilʹsʹkiy oblasti / I. YA. Dzyubanovsʹkyy, T. V. Romanyuk // Visnyk naukovykh doslidzhenʹ. – 2014. – № 2. – S. 18–19.
Tkachova O. V. Chastotnyy analiz likarsʹkykh zaso biv, pryznachenykh dlya likuvannya tsyrozu pechinky v likar ni mista Kharkova / O. V. Tkachova, K. O. Minova // Materi aly VII nauk.-prakt. konf. «Farmakoekonomika v Ukrayi ni: stan ta perspektyvy rozvytku». – KH. : Vyd-vo NfaU, 2014. – S. 55–56.
Runyon Br. A. Introduction to there vised Ameri can Association for the Study of Liver Diseases Practice Guideline managemen to fadult patients with ascitesdue to cirrhosis 2012 / Br. A. Runyon // Hepatology. – 2013. – Vol 57. – P. 1651–1653.
Schuppan D. Liver Cirrhosis / D. Schuppan, N. Afdhal// Lancet. – 2008.– Vol. 371. – P. 838–851.
Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based studyof 1032 pa tients / M. E. Gershwin, C. Selmi, H. J. Worman [et al.] // Hepatology. – 2005. – Vol. 42. – R. 1194–1202.
